News for 'diagnostics'

Omicron: Europe-like surge may mean 1.4 mn cases a day

Omicron: Europe-like surge may mean 1.4 mn cases a day

Rediff.com18 Dec 2021

'We have to ensure the European situation does not occur in India and we don't see a spread like theirs.'

COVID-19 test: Why patients opt out of private labs

COVID-19 test: Why patients opt out of private labs

Rediff.com27 Mar 2020

At present, the cost of testing for COVID-19 is Rs 4,500 per examination and the results are available within 24 hours. Almost 90 per cent of queries fizzle out after patients realise the cost of testing will not be borne by the government.

Fortis to re-brand itself as Parkway

Fortis to re-brand itself as Parkway

Rediff.com15 Aug 2020

The company said this was 'important' to reinforce the 'complete disassociation' from its erstwhile promoters -- Malvinder and Shivinder Singh.

4 IPOs to watch out for in 2022

4 IPOs to watch out for in 2022

Rediff.com22 Mar 2022

Once stability returns to the secondary market, companies that have obtained approval from Sebi will start tapping the market.

4.7 mn Covid deaths in India, says WHO; govt objects

4.7 mn Covid deaths in India, says WHO; govt objects

Rediff.com5 May 2022

India has been consistently objecting to the methodology adopted by the WHO to project excess mortality estimates based on mathematical models, the Union Health Ministry said in a statement.

Covid cases with variants of concern rose from 10% in May to 51% till June 20

Covid cases with variants of concern rose from 10% in May to 51% till June 20

Rediff.com28 Jun 2021

The panel was informed that the economic impact of the second wave of viral infection was "asynchronous in its onset and wider in its spread particularly in rural hinterland", a source said.

Juventus' Rugani, Matuidi recover from COVID-19

Juventus' Rugani, Matuidi recover from COVID-19

Rediff.com16 Apr 2020

The duo were asymptomatic, but the third player, forward Paulo Dybala, showed strong symptoms.

'Investors should allocate more towards large-caps and defensives in the current risk-off scenario'

'Investors should allocate more towards large-caps and defensives in the current risk-off scenario'

Rediff.com13 May 2022

'For the next two years, we expect the bulk of earnings growth contribution from sectors like financials and energy, where the outlook remains positive, while the sectors which are linked to domestic consumption and are currently witnessing strains on margins have low salience for Nifty earnings.'

Tata Motors unveils Tigor EV; sales to begin from Aug 31

Tata Motors unveils Tigor EV; sales to begin from Aug 31

Rediff.com18 Aug 2021

Tata Motors on Wednesday unveiled Tigor EV, its second electric model in the personal mobility space after Nexon EV. The auto major has tasted success with Nexon EV, which currently commands about 70 per cent market share in the domestic electric vehicle segment. The Tigor EV comes powered by the company's high voltage electric architecture - Ziptron - and has been developed based on three pillars of technology, comfort and safety.

Centre says 25 districts have contained COVID-19 spread

Centre says 25 districts have contained COVID-19 spread

Rediff.com13 Apr 2020

The districts are Gondia (Maharashtra), Raj Nand Gaon (Chhattisgarh), Davangiri (Karnataka), South Goa, Wayanad and Kottayam (Kerala), West Imphal (Manipur), Rajouri (J&K), Aizwal West (Mizoram), Mahe in Puducherry, SBS Nagar in Punjab, Patna, Nalanda and Munger in Bihar, Pratapgarh in Rajasthan, Panipat, Rohtak and Sirsa in Haryana, Pauri Garhwal in Uttrakhand and Bhadradari Kothagudem in Telangana.

Juve's Dybala recovers from coronavirus

Juve's Dybala recovers from coronavirus

Rediff.com7 May 2020

In March, Dybala confirmed he and his girlfriend, Oriana Sabatini, tested positive for coronavirus.

How govt plans to buy med devices cheaply for Ayushman

How govt plans to buy med devices cheaply for Ayushman

Rediff.com15 Dec 2019

According to a senior government official, the plan is to do "collective bargaining" for certain medical devices and implants by assuring a bulk requirement to the manufacturers. "The requirement for these devices runs into millions. We assure them that the requirement is going to be in bulk. In return, they should offer us better rates," he said.

11 pm to 5 am Covid-19 curfew in Delhi from today

11 pm to 5 am Covid-19 curfew in Delhi from today

Rediff.com27 Dec 2021

Patients and pregnant women, people out to buy essential items, and those travelling to or from railway stations, bus stops and airports will be exempted from the night curfew that kicks in at 11 pm on Monday due to rising COVID-19 cases in Delhi, according to a DDMA order.

New COVID-19 test can give results in just 45 minutes

New COVID-19 test can give results in just 45 minutes

Rediff.com29 Apr 2020

The test named the "SARS-CoV-2 DETECTR" is easy to implement and to interpret, and requires no specialised equipment, said researchers from the University of California, San Francisco in the US.

ICMR approves TB machines for COVID-19 testing

ICMR approves TB machines for COVID-19 testing

Rediff.com10 Apr 2020

The ICMR has validated 'TruenatTM beta CoV test on TruelabTM workstation' and has recommended it as a screening test,the apex health research body said on Friday.

Made-in-India Covaxin gets WHO's emergency use licence

Made-in-India Covaxin gets WHO's emergency use licence

Rediff.com3 Nov 2021

Covaxin was found to have 78 per cent efficacy against COVID-19 of any severity, 14 or more days after the second dose, and is extremely suitable for low- and middle-income countries due to easy storage requirements, said the global health body.

WHO reminds Serum Institute of COVAX commitments

WHO reminds Serum Institute of COVAX commitments

Rediff.com18 May 2021

COVAX, 'the global COVID vaccine equity scheme', has so far delivered 65 million doses to 124 countries and economies but it is dependent on countries and manufacturers honouring their commitments.

India's COVID-19 recovery rate nearing 60%

India's COVID-19 recovery rate nearing 60%

Rediff.com30 Jun 2020

The number of active COVID-19 cases stands at 2,15,125, while 3,34,821 patients have been cured/discharged.

India's COVID-19 toll tops 50,000; over 57K new cases reported

India's COVID-19 toll tops 50,000; over 57K new cases reported

Rediff.com17 Aug 2020

The number of tests for detection of COVID-19 also crossed the three crore-mark in the country, according to the Indian Council of Medical Research (ICMR). The death toll due to COVID-19 climbed to 50,921 with 941 people succumbing to the disease in a span of 24 hours.

Takeover battle over, Munjal-Burman team bags Fortis

Takeover battle over, Munjal-Burman team bags Fortis

Rediff.com11 May 2018

Their offer values Fortis at over Rs 9,000 crore, or around Rs 172 per share.

India cancels orders for Chinese COVID-19 test kits

India cancels orders for Chinese COVID-19 test kits

Rediff.com27 Apr 2020

India procured around 5 lakh rapid antibody test kits from the two Chinese firms, Guongzhou Wondfo Biotech and Livzon Diagnostics, and they were distributed to several states reporting rising cases of the coronavirus infection.

Covid-19: Mumbai to ramp up testing to 4,000 a day

Covid-19: Mumbai to ramp up testing to 4,000 a day

Rediff.com21 Apr 2020

Mumbai, with an estimated population of nearly 20 million, has been testing 1,200-1,400 people per day. Delay in the delivery of rapid antibody test kits has forced the BMC to restrict its testing net.

Bengal announces complete lockdown from May 16-30 to curb Covid spread

Bengal announces complete lockdown from May 16-30 to curb Covid spread

Rediff.com15 May 2021

During this period, all government and private offices, shopping complexes, malls, bars, sports complexes, pubs and beauty parlours will remain closed.

Revealed: Our Banks' Financial Health

Revealed: Our Banks' Financial Health

Rediff.com12 May 2022

We'll need to wait a couple of years to see how many restructured loans turn bad and whether some banks fall victim to their obsession for growth, explains Tamal Bandyopadhyay.

WHO classifies Indian Covid strain as 'variant of concern'

WHO classifies Indian Covid strain as 'variant of concern'

Rediff.com11 May 2021

The B-1617 variant of the coronavirus, first identified in India, has been classified as a variant of concern at the global level by the World Health Organisation (WHO).

6 flyers from 'at-risk' countries admitted to Delhi's LNJP Hospital

6 flyers from 'at-risk' countries admitted to Delhi's LNJP Hospital

Rediff.com2 Dec 2021

Six Covid-19 cases were reported on Wednesday after screening 3,476 passengers of 11 flights that arrived in India from "at-risk" countries and the samples have been sent for genomic sequencing, the Health Ministry said amid concerns over the 'Omicron' variant of coronavirus.

Budget 2022: Insurers want investment limit of 80C hiked

Budget 2022: Insurers want investment limit of 80C hiked

Rediff.com26 Jan 2022

Insurance companies are seeking a separate deduction limit of Rs 1 lakh for insurance premium payment under Section 80C of the Income Tax Act in the upcoming Union Budget to bring in more people under the ambit of insurance. The insurers also want reduction in the goods and services tax (GST) rate of 18 per cent currently applied on health insurance products to 5 per cent to make such products more affordable to common people. Finance Minister Nirmala Sitharaman will present the Union Budget for 2022-23 on February 1.

Coronavirus death toll crosses 100 in US

Coronavirus death toll crosses 100 in US

Rediff.com18 Mar 2020

The first fatality from COVID-19 was reported from the Washington state on February 26.

Cadila launches Remdesivir in India at Rs 2,800 per vial

Cadila launches Remdesivir in India at Rs 2,800 per vial

Rediff.com13 Aug 2020

The company said the drug will be made available across India through the group's strong distribution chain reaching out to government and private hospitals treating COVID-19 patients.

Coronavirus hits children less severely than adults, says study

Coronavirus hits children less severely than adults, says study

Rediff.com14 Mar 2020

'However, the importance of children in transmitting the virus remains uncertain,' the scientists cautioned in the study. 'Coronaviruses are a large family of viruses that can cause infection and disease in animals, capable of rapid mutation and recombination, leading to novel viruses that can spread from animals to humans,' they said.

No one safe until all vaccinated for Covid: Johns Hopkins scientist

No one safe until all vaccinated for Covid: Johns Hopkins scientist

Rediff.com22 Apr 2022

Vaccine inequity remains an issue in India, where less than 2 per cent of the population has received a Covid booster

Tata Motors launches Tigor EV @ Rs 11.99 lakh

Tata Motors launches Tigor EV @ Rs 11.99 lakh

Rediff.com31 Aug 2021

Tata Motors on Tuesday launched its second electric vehicle -- Tigor EV, catering to the personal segment in the domestic market, priced between Rs 11.99 lakh and Rs 13.14 lakh (ex-showroom). The model comes in three variants, priced at Rs 11.99 lakh, Rs 12.49 lakh and Rs 12.99 lakh. A dual tone top-end trim is tagged at Rs 13.14 lakh. The auto major has already achieved success with its first electric model, Nexon EV and now commences deliveries of Tigor EV from around 150 sales outlets in 70 cities across the country.

COVID-19: France, US deliver oxygen supplies to India

COVID-19: France, US deliver oxygen supplies to India

Rediff.com2 May 2021

France on Sunday delivered to India 28 tonnes of ready-to-use medical supplies including eight large oxygen plants while the US sent to India a third flight that brought over 1000 oxygen cylinders

Revealed: How India launched its war against COVID-19

Revealed: How India launched its war against COVID-19

Rediff.com30 Jul 2020

'The lockdown was for both: To flatten the curve or more correctly, delay the rapid spread of COVID outbreak, and to create healthcare infrastructure.'

About 18-19 COVID vaccine candidates in pipeline: Harsh Vardhan

About 18-19 COVID vaccine candidates in pipeline: Harsh Vardhan

Rediff.com15 Feb 2021

About 18-19 coronavirus vaccine candidates are in different clinical trial stages and may be available in the coming months, Health Minister Harsh Vardhan said on Monday.

Driverless train operations flagged off on Delhi Metro's Pink Line

Driverless train operations flagged off on Delhi Metro's Pink Line

Rediff.com25 Nov 2021

In another milestone for the DMRC, driverless train operations on 59-km Pink Line of the Delhi Metro were flagged off on Thursday.

WHO chief thanks PM for support to global COVID response

WHO chief thanks PM for support to global COVID response

Rediff.com23 Jan 2021

Prime Minister Modi has said India's vaccine production and delivery capacity will be used for the benefit of all humanity to fight the COVID-19 pandemic. He said last week India was ready to do everything possible for a healthy planet.

Trump 'safe' to return to public life on Saturday: Doc

Trump 'safe' to return to public life on Saturday: Doc

Rediff.com9 Oct 2020

Since returning home, his physical exam has remained stable and devoid of any indications to suggest progression of illness, his doctor said.

Second round of sero survey begins in Mumbai

Second round of sero survey begins in Mumbai

Rediff.com10 Aug 2020

The study will provide information about the spread of the infection and also throw light on herd immunity.

Relocating tents, keeping farm movement memories alive

Relocating tents, keeping farm movement memories alive

Rediff.com10 Dec 2021

As the farmers prepare to leave their protest sites on Delhi's borders on Saturday after the government repealed the farm laws and acceded to their other demands, many say they will reinstall their tents in their villages as a symbol of their long, arduous struggle.